These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15056504)

  • 21. Neural systems and cue-induced cocaine craving.
    Bonson KR; Grant SJ; Contoreggi CS; Links JM; Metcalfe J; Weyl HL; Kurian V; Ernst M; London ED
    Neuropsychopharmacology; 2002 Mar; 26(3):376-86. PubMed ID: 11850152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
    Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
    J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.
    Frölich J; Banaschewski T; Döpfner M; Görtz-Dorten A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1169-83. PubMed ID: 24856438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methylphenidate misuse].
    Bruggisser M; Bodmer M; Liechti ME
    Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extreme reduction of methylphenidate levels by carbamazepine.
    Behar D; Schaller J; Spreat S
    J Am Acad Child Adolesc Psychiatry; 1998 Nov; 37(11):1128-9. PubMed ID: 9808919
    [No Abstract]   [Full Text] [Related]  

  • 27. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential.
    Spencer TJ; Biederman J; Martin JM; Moorehead TM; Mirto T; Clarke A; Batchelder H; Faraone SV
    Postgrad Med; 2012 Jan; 124(1):166-73. PubMed ID: 22314126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicokinetic assessment of methylphenidate (Ritalin(R)) in a 13-week oral (gavage) toxicity study in rats using an enantiomeric liquid chromatography/tandem mass spectrometry assay.
    Bakhtiar R; Tse FL
    Rapid Commun Mass Spectrom; 2003; 17(18):2160-2. PubMed ID: 12955748
    [No Abstract]   [Full Text] [Related]  

  • 30. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1242-3. PubMed ID: 9847492
    [No Abstract]   [Full Text] [Related]  

  • 31. Polypharmacy side effects.
    Markowitz J; Patrick K
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):842. PubMed ID: 8768342
    [No Abstract]   [Full Text] [Related]  

  • 32. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of potential agonist-replacement therapies for stimulant dependence on inhibitory control in cocaine abusers.
    Vansickel AR; Fillmorex MT; Hays LR; Rush CR
    Am J Drug Alcohol Abuse; 2008; 34(3):293-305. PubMed ID: 18428072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limbic responsiveness to procaine in cocaine-addicted subjects.
    Adinoff B; Devous MD; Best SM; George MS; Alexander D; Payne K
    Am J Psychiatry; 2001 Mar; 158(3):390-8. PubMed ID: 11229979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission.
    Volkow ND; Wang GJ; Fowler JS; Telang F; Jayne M; Wong C
    Am J Psychiatry; 2007 Jan; 164(1):157-60. PubMed ID: 17202559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects.
    Volkow ND; Wang GJ; Ma Y; Fowler JS; Wong C; Jayne M; Telang F; Swanson JM
    Neuroimage; 2006 Oct; 32(4):1782-92. PubMed ID: 16757181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
    Coetzee M; Kaminer Y; Morales A
    Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The scientific exegesis of desire: neuroimaging crack craving.
    Gawin FH
    Arch Gen Psychiatry; 2001 Apr; 58(4):342-4. PubMed ID: 11296094
    [No Abstract]   [Full Text] [Related]  

  • 40. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.